ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018
4L Lymph Node Involvement in Left-Sided Lung Cancer: Unique or Not?
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.Frontiers in oncology · 2025Pooled it
- Computed tomography-based radiomics model for predicting station 4 lymph node metastasis in non-small cell lung cancer.BMC medical imaging · 2025Article
- EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma.BMC cancer · 2025Article
- Significance of risk factor analysis and dissection for station 4L lymphatic metastasis in left lung cancer: a systematic review and meta-analysis.Translational cancer research · 2021Article
- [Clinicopathological characteristics and risk factors of station 4L lymph node metastasis of left non-small cell lung cancer].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020Article
- Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.Journal of translational medicine · 2020Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
30148657What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.